Valuation: Cutia Therapeutics

Market Cap 76Cr 88Cr 11Cr 9.81Cr 9.16Cr 8.4Cr 16Cr 1.07TCr 16Cr 108.59Cr 42Cr 529.21Cr 42Cr 41Cr 1.83TCr P/E 2026 *
-4.54x
P/E 2027 * 16x
Enterprise Value 82Cr 96Cr 12Cr 11Cr 9.99Cr 9.17Cr 17Cr 1.17TCr 18Cr 118.46Cr 46Cr 577.3Cr 46Cr 45Cr 2TCr EV / Sales 2026 *
1.28x
EV / Sales 2027 * 0.64x
Free-Float
35.23%
Yield 2026 *
-
Yield 2027 * -
1 week-7.66%
Current month-14.84%
1 month-10.74%
3 months-47.72%
6 months-47.49%
Current year-46.92%
1 week 2.14
Extreme 2.14
2.67
1 month 2.14
Extreme 2.14
2.88
Current year 2.14
Extreme 2.14
5.51
1 year 2.14
Extreme 2.14
12
3 years 2.14
Extreme 2.14
31
5 years 2.14
Extreme 2.14
32.6
10 years 2.14
Extreme 2.14
32.6
Manager TitleAgeSince
Chief Executive Officer 48 01/09/2019
Director of Finance/CFO 36 10/05/2021
Chief Tech/Sci/R&D Officer 42 10/01/2020
Director TitleAgeSince
Director/Board Member 48 12/05/2020
Chairman 63 23/08/2019
Director/Board Member 36 15/11/2022
Date Insider Type Main position Quantity % Market Cap.
15/10/24 Other

Founder

15,000 0.0049%
03/10/24 Other

Chief Financial Officer

20,000 0.0066%
02/10/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-7.66%-74.79%-88.41% 11Cr
-0.58%+4.53%+59.34%+167.45% 1,08900Cr
-0.32%+3.99%+58.12%+58.67% 64TCr
+0.31%+4.82%+38.85%+77.51% 47TCr
-1.69%+8.81%+39.38%+33.67% 36TCr
-0.51%+3.51%+36.97%+42.46% 30TCr
+1.50%+3.40%+17.71%+17.41% 27TCr
+0.79%+5.81%-2.55%-38.10% 23TCr
-1.39%+6.34%+28.23%+66.24% 21TCr
-1.18%+2.88%+17.39%+76.12% 17TCr
Average -0.42%+3.61%+21.87%+41.30% 37.31TCr
Weighted average by Cap. -0.62%+4.87%+42.46%+81.42%

Financials

2026 *2027 *
Net sales 65Cr 75Cr 9.54Cr 8.38Cr 7.82Cr 7.18Cr 13Cr 913.66Cr 14Cr 93Cr 36Cr 452.11Cr 36Cr 35Cr 1.56TCr 117.98Cr 136.66Cr 17Cr 15Cr 14Cr 13Cr 25Cr 1.67TCr 25Cr 169.47Cr 66Cr 825.86Cr 65Cr 64Cr 2.85TCr
Net income -15Cr -17Cr -2.15Cr -1.89Cr -1.77Cr -1.62Cr -3.03Cr -206.15Cr -3.11Cr -21Cr -8.19Cr -102.01Cr -8.08Cr -7.91Cr -352.66Cr 4.42Cr 5.13Cr 65.35L 57.42L 53.6L 49.19L 92.08L 63Cr 94.35L 6.36Cr 2.49Cr 31Cr 2.45Cr 2.4Cr 107.08Cr
Net Debt 6.87Cr 7.96Cr 1.01Cr 89.15L 83.22L 76.37L 1.43Cr 97Cr 1.46Cr 9.87Cr 3.86Cr 48Cr 3.81Cr 3.73Cr 166.24Cr -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
304
Date Price Change Volume
29/26/29 HK$2.410 0.00% 400
28/26/28 HK$2.410 -3.60% 30,400
27/26/27 HK$2.500 +3.73% 1,22,400
24/26/24 HK$2.410 -6.23% 2,32,400
23/26/23 HK$2.570 +0.78% 32,400
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.081CNY
Average target price
9.801CNY
Spread / Average Target
+371.08%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock